Back
Aclaris Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ACRS
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
10
ACRS
Aclaris Therapeutics
Last Price:
1.18
Seasonality Move:
-3.2%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Aclaris Therapeutics Price Quote
$1.18
-0.04 (-3.28%)
(Updated: April 24, 2024 at 6:55 PM ET)
Aclaris Therapeutics Key Stats
Sell
10
Aclaris Therapeutics (ACRS)
is a Sell
Day range:
$1.22 - $1.25
52-week range:
$0.59 - $11.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.73
P/B ratio:
0.55%
Volume:
603.7K
Avg. volume:
775.8K
1-year change:
-86.67%
Market cap:
$86.5M
Revenue:
$31.2M
EPS:
$-1.27
How Much Does Aclaris Therapeutics Make?
-
How Much Are Aclaris Therapeutics's Sales Annually?
ACRS Revenues are $31.2M -
How Much Profit Does Aclaris Therapeutics's Make A Year?
ACRS net income is -$88.5M
Is Aclaris Therapeutics Growing As A Company?
-
What Is Aclaris Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.27% -
What Is Aclaris Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aclaris Therapeutics Stock Price Performance
-
Did Aclaris Therapeutics Stock Go Up Last Month?
Aclaris Therapeutics share price went up by 6.09% last month -
Did ACRS's Share Price Rise Over The Last Year?
ACRS share price fell by -86.67% over the past 1 year
What Is Aclaris Therapeutics 52-Week High & Low?
-
What Is Aclaris Therapeutics’s 52-Week High Share Price?
Aclaris Therapeutics has traded as high as $11.12 over the past 52 weeks -
What Is Aclaris Therapeutics’s 52-Week Low Share Price?
Aclaris Therapeutics has traded as low as $0.59 over the past 52 weeks
Aclaris Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aclaris Therapeutics?
-
How Much Debt Does Aclaris Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aclaris Therapeutics Have?
Cash and short term investments quarterly total is $119.1M -
What Is Aclaris Therapeutics’s Book Value Per Share?
Book value per share is 2.22
Is Aclaris Therapeutics Cash Flow Positive?
-
What Is ACRS Cash Flow From Operations?
Cash flow from operations (TTM) is -$78.3M -
What Is Aclaris Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.7M -
What Is Aclaris Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $46.2M
Aclaris Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ACRS return on invested capital is -50.99% -
What Is Aclaris Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -38.95% -
What Is ACRS Return On Equity?
ROE is a measure of profitability and is -50.99%
Aclaris Therapeutics Earnings Date & Stock Price
-
What Is Aclaris Therapeutics's Stock Price Today?
A single share of ACRS can be purchased today for 1.22 -
What Is Aclaris Therapeutics’s Stock Symbol?
Aclaris Therapeutics trades on the nasdaq under the ticker symbol: ACRS -
When Is Aclaris Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aclaris Therapeutics is scheduled on May 8, 2024 -
When Is ACRS's next ex-dividend date?
Aclaris Therapeutics's next ex-dividend date is April 25, 2024 -
How To Buy Aclaris Therapeutics Stock?
You can buy Aclaris Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aclaris Therapeutics Competitors
-
Who Are Aclaris Therapeutics's Competitors?
Below is a list of companies who compete with Aclaris Therapeutics or are related in some way:
Aclaris Therapeutics Dividend Yield
Data Unavailable
Aclaris Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 94.85% |
Revenue: | 126.62% | 247.87% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 1.80 |
Upside from Last Price: | 47.54% |